2013
April 3, 2013: Grand MMTI Fellow, Dr. Michael Pourdehnad, awarded the 2013 AACR-Millennium Fellowship in Lymphoma Cancer Research to advance his work on determining the role of oncogenic translational factors in multiple myeloma drug-resistance.
2012
June 14, 2012: Cancer’s Next Magic Bullet May Be Magic Shotgun
April 15, 2012: AACR Inducts Frank McCormick, PhD, FRS, DSc (hon) as President
April 2, 2012: UCSF’s Frank McCormick now leads world’s largest cancer research association
February 22, 2012: Cancer Research Shows Promise of New Drugs
2011
December 23, 2011: A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired for $190 million
December 22, 2011: Peter Walter Awarded €100,000 Paul Ehrlich and Ludwig Darmstaedter Prize in 2012 for Uncovering How Cells Cope with Stress
September 27, 2011: Peter Walter Awarded Otto Warburg Medal
April 20, 2011: Kevan Shokat Elected to American Academy of Arts and Sciences
March 30, 2011: James Wells receives the Bristol-Myers Squibb Smissman Awards
March 22, 2011: AACR Names Frank McCormick New President-Elect
2010
July 29, 2010: Frank McCormick is Honored by the American Society of Clinical Oncology
July 19, 2010: UCSF Spinoff Calithera Shows Promise of Translational Research
July 7, 2010: Mission Bay Capital invests in UCSF cancer therapy spinoff with technology licensed from the laboratory of Jim Wells
June 9, 2010: A One-Stop Shop for Myeloma Research
April 9, 2010: Wells wins ASBMB-Merck Award
March 16, 2010: Blocking Cancer in its Path: New Cellular Defect Discovered
2009
July 2009: $2M Gift from Grands Launches Multiple Myeloma Initiative
May 1, 2009: Kevan Shokat elected to National Academy of Sciences
April 8, 2009: Peter Walter Wins Gaidner International Award